IDYA ▲ +1.1% - IDEAYA Biosciences, Inc.
$IDYA IDYA - IDEAYA Biosciences Announces Development Candidate Nomination of IDE101, a Potential First-In-Class Inhibitor Targeting CDKN2A-Deficiency in Solid Tumors
15-NOV-2026 03:00 PM ET
Share this post
More filings for $IDYA
IDYA ▲ +0.1% - IDEAYA Biosciences, Inc.Nov 4, 2026IDYA ▲ +0.4% - IDEAYA Biosciences, Inc.Oct 19, 2026IDYA ▲ +2.2% - IDEAYA Biosciences, Inc.Aug 31, 2026IDYA ▲ +0.2% - IDEAYA Biosciences, Inc.Aug 28, 2026$IDYA SEC Filing Update (31-JUL-2026) | ThinkSabio - Stocks SimplifiedJul 31, 2026
View full $IDYA filing history →💬 Comments
Loading comments…
Leave a comment